Pathway-driven discovery of rare mutational impact on cancer

Area of Science:

• Genomics
• Bioinformatics
• Cancer Research

Background:

• Identifying driver mutations is crucial for understanding disease mechanisms and developing targeted therapies.
• Current functional analyses often overlook the impact of mutations on gene expression networks.
• Complex regulatory networks can lead to differential gene expression in genes functionally related to mutated genes.

Purpose of the Study:

• To develop a new computational approach for discovering rare mutations with significant pathway-level impact.
• To identify mutations that can statistically discriminate pathway-level mRNA expression between patient groups.
• To apply this method to breast cancer data for identifying novel driver mutations.

Main Methods:

• Iteratively combining rare mutations until statistical significance in pathway-level mRNA expression is achieved.
• Analyzing somatic mutation and mRNA expression data from breast cancer patients.
• Utilizing a pathway-centric approach to assess mutational impact.

Main Results:

• The developed approach effectively captures mutations altering pathway-level mRNA expression.
• Previously identified breast cancer driver mutations (TP53, PIK3CA, RB1) were successfully detected.
• Mutational events in 32 genes, not previously highlighted, were identified as showing pathway-level mRNA expression differences among 15,819 genes analyzed.

Conclusions:

• The novel method sensitively identifies rare mutations impacting pathway mRNA expression.
• This approach enhances the discovery of clinically relevant driver mutations in cancer.
• The findings provide new insights into the genetic landscape of breast cancer and potential therapeutic targets.